Home  »  Company   »  Is Plus Therapeutics Inc. (NASDAQ:PSTV), -340.82% ...

Is Plus Therapeutics Inc. (NASDAQ:PSTV), -340.82% Below Its High, Poised For A Strong Recovery?

In recent trading session, Plus Therapeutics Inc. (NASDAQ:PSTV) saw 2.05 million shares changing hands at last check today with its beta currently measuring 0.13. Company’s recent per share price level of $0.49 trading at $0.0 or 0.97% at last check today assigns it a market valuation of $16.28M. That most recent trading price of PSTV’s stock is at a discount of -340.82% from its 52-week high price of $2.16 and is indicating a premium of 20.41% from its 52-week low price of $0.39. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.16 million shares which gives us an average trading volume of 4.07 million if we extend that period to 3-months.

For Plus Therapeutics Inc. (PSTV), analysts’ consensus is at an average recommendation of a Buy. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.22 in the current quarter.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Plus Therapeutics Inc. (NASDAQ:PSTV) trade information

Upright in the green today for gaining 0.97%, in the last five days PSTV remained trading in the red while hitting it’s week-highest on Friday, 09/16/22 when the stock touched $0.49 price level, adding 19.67% to its value on the day. Plus Therapeutics Inc.’s shares saw a change of -53.71% in year-to-date performance and have moved -19.00% in past 5-day. Plus Therapeutics Inc. (NASDAQ:PSTV) showed a performance of -29.54% in past 30-days. Number of shares sold short was 0.55 million shares which calculate 0.05 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $3.50 to the stock, which implies a rise of 86.0% to its recent value today. Analysts have been projecting $2.00 as a low price target for the stock while placing it at a high target of $5.00. It follows that stock’s current price would drop -920.41% in reaching the projected high whereas dropping to the targeted low would mean a loss of -308.16% for stock’s current value.

Plus Therapeutics Inc. (PSTV) estimates and forecasts

Statistics highlight that Plus Therapeutics Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -51.40% of value to its shares in past 6 months, showing an annual growth rate of 25.23% while that of industry is 11.70. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 12.00% in the current quarter and calculating 15.40% increase in the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 71.90% during past 5 years.

PSTV Dividends

Plus Therapeutics Inc. is more likely to be releasing its next quarterly report between October 19 and October 24 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Plus Therapeutics Inc. (NASDAQ:PSTV)’s Major holders

Insiders are in possession of 1.13% of company’s total shares while institution are holding 11.00 percent of that, with stock having share float percentage of 11.12%. Investors also watch the number of corporate investors in a company very closely, which is 11.00% institutions for Plus Therapeutics Inc. that are currently holding shares of the company. Parkman Healthcare Partners LLC is the top institutional holder at PSTV for having 1.53 million shares of worth $0.74 million. And as of Jun 29, 2022, it was holding 4.71% of the company’s outstanding shares.

The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 0.86 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 2.63% of outstanding shares, having a total worth of $0.41 million.

On the other hand, Vanguard Total Stock Market Index Fund and Professionally Managed Portf-Otter Creek Long Short Opportunity Fd are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 0.69 million shares of worth $0.33 million or 2.11% of the total outstanding shares. The later fund manager was in possession of 0.33 million shares on Apr 29, 2022, making its stake of worth around $0.16 million in the company or a holder of 1.01% of company’s stock.

Leave a Comment

Your email address will not be published.

On Key

Related Posts